Thrive With Type 1 Diabetes 2026
Sponsored by Emory University
About this study
This study aims to learn whether a cognitive behavioral intervention can improve lifestyle and glucose targets for adults with type 1 diabetes.
Type 1 diabetes (T1D), a common yet understudied chronic condition in young adulthood, is a life-shortening disorder leading to beta-cell destruction and absolute insulin deficiency. Suboptimal glucose diabetes self-management is associated with a higher risk for premature vascular complications, both macrovascular (e.g., coronary artery disease, peripheral arterial disease, and stroke) and microvascular (retinopathy, nephropathy, neuropathy) through accelerated vascular aging. Yet a majority of adults with T1D do not achieve recommended glycemic targets (A1C \<7%) or blood pressure targets.
Where this study is enrolling (2)
- I'm interested
Emory University, Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia
- I'm interested
Emory University
Atlanta, Georgia
Who can participate
Inclusion criteria
- ✓Aged 31 to 75 years
- ✓Type 1 Diabetes for at least 1 year
- ✓One or more sleep health dimensions are out of range
Exclusion criteria
- ✕Non-English speaking
- ✕Recent night shift work or transmeridian travel
- ✕Life-limiting illness
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.